- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Cygene Laboratories Inc
CYGE:US
Ticker Delisted
Snapshot for Cygene Laboratories Inc (CYGE)
| Open: | - | Day's Range: | - | Volume: | 0 | Bid: | - |
|---|---|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - | Ask: | - |
Key Statistics for CYGE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (-) | - |
| Earnings Per Share () (ttm) | -0.0930 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 58.02 |
| Enterprise Value (M USD) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | - |
More CYGE Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for CYGE
No data available.
Company Profile & Key Executives for CYGE
CyGene Laboratories Inc. is seeking to market commercialized genetic testing to the public. The Company develops proprietary and automated DNA and RNA testing systems for the screening, monitoring, and diagnosis of human, veterinary, and plant diseases. CyGene's primary development focus is blood screening tests for the West Nile Virus and the detection of biological warfare agents.
| Martin MunzerPresident/CEO | Barry H DvorchikVP:Drug Development |
| Peter J LaurenceVP:Business Development | Jeffrey PincoDirector:Laboratory |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page